Research Topics
| Ashok R ShahaSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
TNM classification of thyroid carcinomaAshok R Shaha
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10021, USA
World J Surg 31:879-87. 2007..The TNM staging system helps reporting our data and comparing results in different parts of the world. However, there is no level I evidence in thyroid cancer...
Predictors of outcome for advanced-stage supraglottic laryngeal cancerIan Ganly
Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Head Neck 31:1489-95. 2009..The objective of this study was to report our experience in the management of patients with advanced-stage supraglottic laryngeal carcinoma and to identify factors predictive of outcome...
Incidence and significance of Delphian node metastasis in papillary thyroid cancerN Gopalakrishna Iyer
Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York 10065, USA
Ann Surg 253:988-91. 2011..The objective of this study was to determine the incidence and significance of Delphian node (DN) metastasis in papillary thyroid cancer...
Disease-related death in patients who were considered free of macroscopic disease after initial treatment of well-differentiated thyroid carcinomaIain J Nixon
Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Thyroid 21:501-4. 2011..3%). In contrast to earlier reports, death caused by central compartment disease in this recent series is very rare, with metastatic disease accounting for almost all fatalities...
Lymph node density is a significant predictor of outcome in patients with oral cancerZiv Gil
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Cancer 115:5700-10. 2009..In the current study, the utility of lymph node density (LND) was evaluated as an alternative method for predicting survival...
Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancerRamesh Rengan
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Am J Clin Oncol 31:465-9. 2008..To examine the long-term neck failure outcome in patients with advanced head and neck cancer treated on larynx/organ preservation protocols at Memorial Sloan-Kettering Cancer Center...
Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanomaBenjamin E Saltman
Department of Otolaryngology, Division of Head and Neck Surgery, Long Island Jewish Medical Center, New Hyde Park, NY, USA
Head Neck 32:1686-92. 2010..The goal of this study is to report the results of SLNB for head and neck cutaneous melanoma in locating the sentinel node and to report on the prognostic implications of SLNB for this cohort of patients...
Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancerDaniel R Gomez
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 81:e207-13. 2011..However, the incidence of this complication with intensity-modulated radiation therapy (IMRT) and dental sequelae with this technique have not been fully elucidated...
The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancerIain J Nixon
Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Surgery 150:1242-9. 2011....
Analysis of postoperative complications of open partial laryngectomyIan Ganly
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Head Neck 31:338-45. 2009..The objective of this study was to report the incidence of postoperative complications for partial laryngectomy and to identify patient- and tumor-related factors predictive of postoperative complications...
Delphian node metastasis in head and neck cancers--oracle or myth?N Gopalakrishna Iyer
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
J Surg Oncol 102:354-8. 2010..In this article, we review the existing literature on the topic to determine the significance of DN metastasis in laryngeal, hypopharyngeal and thyroid cancers...
Micromedullary thyroid cancer: how micro is truly micro?Venu G Pillarisetty
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 16:2875-81. 2009..The aggressive nature of medullary thyroid cancer (MTC) is evidenced by its propensity to present early with lymph node (LN) metastases. The clinical significance of sporadic MTC < or =1 cm (micro-MTC) is not clearly defined...
Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neckVolkert B Wreesmann
Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 22:3965-72. 2004..A sequential approach to control for multiple comparisons and effect of confounding variables allows the identification of clinically relevant aberrations. The significance of each individual abnormality merits further consideration...
Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynxIan Ganly
Department of Head and Neck Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Arch Otolaryngol Head Neck Surg 132:59-66. 2006..These patients have poorer survival outcomes manifested by local, regional, and distant disease progression...
Thyroid isthmusectomy for well-differentiated thyroid cancerIain J Nixon
Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 18:767-70. 2011..This study was designed to analyze outcomes in patients treated with isthmusectomy for small well-differentiated thyroid cancer (WDTC) at our institution...
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experienceStephanie A Terezakis
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 73:795-801. 2009..External beam radiotherapy (EBRT) plays a controversial role in the management of nonanaplastic thyroid cancer. We reviewed our institution's outcomes in patients treated with EBRT for advanced or recurrent nonanaplastic thyroid cancer...
Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapyN Gopalakrishna Iyer
Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Cancer 117:4439-46. 2011..The objective of this study was to evaluate patterns of RAI use and elevated risk of secondary primary malignancies (SPM) in patients with low-risk (T1N0) WDTC...
Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinomaIan Ganly
Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 25:1369-76. 2007..To identify genes related to angiogenesis/metastasis that predict locoregional failure in patients with laryngopharyngeal cancer (LPC) undergoing chemoradiotherapy (CRT) treatment...
Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynxKaren Lin
Head and Neck Service, Department of Surgery, P. O. Box 285, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York 10021, USA
Head Neck 27:1042-8. 2005..CONCLUSIONS: The rates of SPMADT after treatment of SCCOC and SCCL are comparable, but the patterns are different. Smoking and alcohol use are independent predictors of SPMADT development...
Contemporary management of cancer of the oral cavityEric M Genden
Department of Otolaryngology Head and Neck Surgery, The Mount Sinai Medical Center, New York, NY, USA
Eur Arch Otorhinolaryngol 267:1001-17. 2010..The purpose of this review is to discuss the most current management options for oral cavity cancers...
Electronic synoptic operative reporting for thyroid surgery using an electronic data management system: potential for prospective multicenter data collectionN Gopalakrishna Iyer
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 18:762-6. 2011..Thyroid surgery lends itself to synoptic reporting, because there are a predefined number of essential intraoperative events and findings that every endocrine surgeon invariably records...
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigmDavid G Pfister
Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 24:1072-8. 2006..Cetuximab has activity in squamous cell carcinoma and enhances both chemotherapy and radiotherapy. We conducted a pilot phase II study of a new combined-modality paradigm of targeted therapy (cetuximab) with chemoradiotherapy...
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancerYungpo Bernard Su
Department of a Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer J 12:182-8. 2006..To evaluate the ability of granulocyte-stimulating factor to decrease mucositis during postoperative radiotherapy for stage II-IV squamous head and neck cancer in a randomized, double-blind, placebo-controlled trial...
Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levelsSeng C Ong
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Nucl Med 48:501-7. 2007..The role of (18)F-FDG PET in MTC remains somewhat unclear. We reviewed our own experience with (18)F-FDG PET in postthyroidectomy MTC patients with elevated calcitonin...
Airway management in anaplastic thyroid carcinomaAshok R Shaha
Head and Neck Surgery, Cornell University Medical Center, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Laryngoscope 118:1195-8. 2008..In patients who present with advanced anaplastic thyroid cancer, airway management is difficult because of bilateral vocal cord paralysis or tracheal invasion by the tumor. Airway management can be extremely complex in these patients...
Current trends in initial management of laryngeal cancer: the declining use of open surgeryCarl E Silver
Department of Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
Eur Arch Otorhinolaryngol 266:1333-52. 2009..While supracricoid laryngectomy has been employed for selected patients, total laryngectomy is the usual procedure for salvage of failure after non-surgical treatment...
Surgical management of metastases to the thyroid glandIain J Nixon
Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 18:800-4. 2011..Metastases to the thyroid gland are uncommon, with rates reported between 0.02% and 1.4% of surgically resected thyroid specimens. Our goal was to present our experience with surgical management of metastases to the thyroid gland...
Fine-needle aspiration biopsy of salivary gland lesions in a selected patient populationErik G Cohen
Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Arch Otolaryngol Head Neck Surg 130:773-8. 2004..The predictive value of a negative FNAB finding is low, and should not supersede clinical suspicion. Cytologic findings of a lymphocyte-predominant lesion should prompt further workup to rule out lymphoma...
Radiotherapy after surgical resection for head and neck mucosal melanomaAbraham J Wu
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
Am J Clin Oncol 33:281-5. 2010..To present our single-institution experience with postoperative radiotherapy for mucosal melanoma of the head and neck...
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysisCherry L Estilo
Dental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, USA
BMC Cancer 9:11. 2009..The present study is aimed at identifying potential candidate genes as prognostic markers in human oral tongue squamous cell carcinoma (SCC) by large scale gene expression profiling...
Thyroid incidentalomas: to treat or not to treatN G Iyer
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Eur Arch Otorhinolaryngol 267:1019-26. 2010..We propose a pragmatic algorithm when faced with this clinical dilemma under differing circumstances...
TALK score: Development and validation of a prognostic model for predicting larynx preservation outcomeEric J Sherman
Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
Laryngoscope 122:1043-50. 2012..To develop and validate a simple prognostic tool that would help predict larynx preservation outcome...
Thyroid and parathyroid surgery in pregnancyRandall P Owen
Department of Surgery, Division of Metabolic, Endocrine and Minimally Invasive Surgery, Mount Sinai School of Medicine, New York, NY, USA
Eur Arch Otorhinolaryngol 267:1825-35. 2010..In general, thyroid surgery can be delayed until after delivery except in cases of airway compromise or aggressive cancer. In contrast, parathyroid surgery is recommended during pregnancy to avoid adverse effects to the neonate...
Factors predicting outcome in malignant minor salivary gland tumors of the oropharynxN Gopalakrishna Iyer
Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Arch Otolaryngol Head Neck Surg 136:1240-7. 2010..to report our experience in the care of patients with minor salivary gland cancers occurring only in the oropharynx and to determine factors predictive of outcome...
FDG-PET detected thyroid incidentalomas: need for further investigation?Chandrakanth Are
Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, 1233 York Avenue, 16 I, New York, New York, 10021, USA
Ann Surg Oncol 14:239-47. 2007..Incidental thyroid abnormalities are increasingly detected in patients undergoing PET scans. The aim of this study was to review our experience with the management of PET detected thyroid incidentalomas in a large single institution series...
Management of mandibular invasion: when is a marginal mandibulectomy appropriate?Eric M Genden
Department of Otolaryngology-Head and Neck Surgery, Mount Sinai School of Medicine, New York, NY, USA
Oral Oncol 41:776-82. 2005..The following is a review of the current literature regarding mandibular invasion and the indications for a marginal mandibulectomy...
Referral guidelines for suspected cancer of the head and neckEric M Genden
Department of Otolaryngology and Head and Neck Surgery, The Mount Sinai School of Medicine, New York, NY, USA
Auris Nasus Larynx 33:1-5. 2006..CONCLUSION: Physician awareness and symptom guidelines may prove effective in expediting the care of patients with head and neck cancer...
MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomasKepal N Patel
Laboratory of Epithelial Cancer Biology, Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Surgery 138:994-1001; discussion 1001-2. 2005..Retrovirally delivered anti-MUC1 RNAi is effective in silencing MUC1 and merits further investigation to establish therapeutic efficacy and safety in anticipation of potential clinical application...
Revision thyroid surgery - technical considerationsAshok R Shaha
Memorial Sloan Kettering Cancer Center, Cornell University Medical College, New York, NY 10065, USA
Otolaryngol Clin North Am 41:1169-83, x. 2008..Despite good surgical resection, the incidence of local recurrence in the central compartment is high in patients undergoing reoperative thyroid surgery...
Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entityVolkert B Wreesmann
Laboratory of Epithelial Cancer Biology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Genes Chromosomes Cancer 40:355-64. 2004..Our findings suggest a stronger relationship between the FVPTC and FTA/FTC than previously appreciated and support further consideration of the current classification of thyroid neoplasms...
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic reviewEric J Sherman
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, United States
Radiother Oncol 101:425-30. 2011..We evaluated our more recent experience with this approach, which included pathologic confirmation of all cases...
Implications of prognostic factors and risk groups in the management of differentiated thyroid cancerAshok R Shaha
Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Laryngoscope 114:393-402. 2004..The study describes the author's treatment approach related to the extent of thyroidectomy and adjuvant therapy based on various risk groups and the long-term survival...
Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trialDavid G Pfister
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Clin Oncol 28:2565-70. 2010..To determine whether acupuncture reduces pain and dysfunction in patients with cancer with a history of neck dissection. The secondary objective is to determine whether acupuncture relieves dry mouth in this population...
Medical management of thyroid cancer: a risk adapted approachR Michael Tuttle
Joan and Sanford I Weill Medical College of Cornell University, New York, New York 10021, USA
J Surg Oncol 97:712-6. 2008....
Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family membersAshok R Shaha
Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Laryngoscope 116:1704-7. 2006..However, its indications in adults remain unclear at this time...
Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survivalLuc G T Morris
Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Thyroid 20:153-8. 2010..Our objective was to utilize a large cancer registry to obtain sufficient power to differentiate between outcomes in cases of TCV and PTC...
Invited commentary: Vocal cord evaluation in thyroid surgeryAshok R Shaha
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Surgery 139:363-4. 2006
Nutrition management of patients with malignancies of the head and neckJames Paul O'Neill
Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Surg Clin North Am 91:631-9. 2011..In this article, the authors explore the nutritional requirements of these patients and the impact of a multidisciplinary therapeutic approach to head, neck, and skull base cancer care...
Improved outcomes in patients with osteogenic sarcoma of the head and neckSnehal G Patel
Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer 95:1495-503. 2002..The results of the current study represent a considerable improvement over the authors' previously published experience and compare favorably with the results reported in the literature...
Hürthle cell carcinoma: a 60-year experienceAlexander Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 9:197-203. 2002..Recurrence portends a poor outcome. High-risk patients and those with recurrence should be considered for adjuvant therapy...
Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancerBenjamin D Rosenbluth
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 63:1419-26. 2005..Ideal planning target volume doses have yet to be determined. Additional patients and long-term follow-up are needed to confirm these preliminary findings and to clarify late toxicities...
Clinical curiosity: cribriform-morular variant of papillary thyroid carcinomaKimberly M Dalal
Division of Head and Neck Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Head Neck 28:471-6. 2006..The first patient subsequently underwent colonoscopy, which was negative for polyposis. CONCLUSIONS: Patients diagnosed with the cribriform-morular variant of papillary thyroid cancer should be screened for the presence of FAP...
Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic markerVolkert B Wreesmann
Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer Res 64:3780-9. 2004..3; 95% confidence interval, 1.1-5.5; P = 0.03). Our data suggest that MUC1 dysregulation is associated with aggressive behavior of PTC and may serve as a prognostic marker and potential therapeutic target in this disease...
Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approachesChandrakanth Are
Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, 1233 York Avenue, 16 I, New York, New York 10021, USA
Ann Surg Oncol 13:453-64. 2006..We also reviewed the individual and combined roles of surgery, radiotherapy, chemotherapy, and newer therapeutic options in the management of ATC...
Minimally invasive parathyroidectomy: the role of radio-guided surgeryAshok R Shaha
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Laryngoscope 112:2166-9. 2002..Objectives were to review our current experience with radio-guided parathyroid surgery and to compare various techniques of minimally invasive parathyroidectomy...
Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposureBhuvanesh Singh
Laboratory of Epithelial Cancer Biology, Biology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, USA
BMC Genet 3:22. 2002..We used comparative genomic hybridization (CGH) to screen for the genetic aberrations in 71 patients with head and neck squamous cell carcinoma and stratified the findings by the status of tobacco/alcohol exposure...
Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysisAlexander Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Hum Pathol 34:54-64. 2003..The molecular phenotype, p27(+)Bcl-2(+)Ki-67(-)mdm2(+), appears to be unique to nonmalignant parathyroid tumors, and multimarker phenotypes are more complex in carcinomas...
Current management of tonsillar cancerEric M Genden
Department of Otolaryngology-Head and Neck Surgery, Mount Sinai School of Medicine, New York, New York, USA
Oral Oncol 39:337-42. 2003..While advanced lesions are often treated with a combination of radiation, chemotherapy, and surgical ablation, management of the neck and distant metastases continues to present a therapeutic dilemma...
The role of operations for distantly metastatic well-differentiated thyroid carcinomaAlexander Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Surgery 131:636-43. 2002..Complete metastasectomy may be associated with improved survival for localized distant disease. Palliative resection is indicated to improve quality of life for symptomatic distant metastasis...
Prediction of survival in patients with head and neck cancer using the histoculture drug response assayBhuvanesh Singh
Head and Neck and Medical Oncology Services, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Head Neck 24:437-42. 2002..In this study, we have correlated the HDRA assessment with survival in patients with head and neck squamous cell carcinoma (HNSCC)...
Parathyroid re-explorationAshok R Shaha
Head and Neck Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Otolaryngol Clin North Am 37:833-43, x. 2004..This article discusses the issues the parathyroid surgeon must consider before and during re-operative surgery,with special attention to recently introduced adjunctive techniques...
Primary mucosal malignant melanoma of the head and neckSnehal G Patel
Head and Neck Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Head Neck 24:247-57. 2002..This study aims to assess the outcome and identify clinical and histologic prognostic indicators in a recent cohort of patients with MMHN treated at a single institution...
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomasBhuvanesh Singh
Laboratory of Epithelial Cancer Biology, The Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Am J Pathol 161:365-71. 2002..6; 95% confidence interval = 1.9 to 29.6). The findings suggest that the 3q copy number status is an important marker for tumor progression and prognostication in patients with head and neck squamous cell carcinoma...
Role of tracheal resection in thyroid cancerNatalya Chernichenko
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Curr Opin Oncol 24:29-34. 2012..To provide a critical review of recent literature on the role of tracheal resection in thyroid cancer...
Poorly differentiated and anaplastic thyroid cancerKepal N Patel
Department of Surgery, Stony Brook University Hospital, Stony Brook, New York, USA
Cancer Control 13:119-28. 2006..CONCLUSIONS: PDTC and ATC are rare diseases that carry a poor prognosis. Recognition of their different clinicopathologic features is important to the optimal management of these tumors...
Medullary thyroid carcinomaErik G Cohen
Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Acta Otolaryngol 124:544-57. 2004
Locally advanced thyroid cancerKepal N Patel
Head and Neck Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Curr Opin Otolaryngol Head Neck Surg 13:112-6. 2005..The understanding and recognition of histopathological variations, such as poorly differentiated thyroid cancer is also important. New molecular markers are needed to help identify and predict aggressive tumor behavior...
Treatment considerations for head and neck cancer in the elderlyEric M Genden
Department of Otolaryngology-Head and Neck Surgery, Mount Sinai School of Medicine, New York, NY, USA
J Laryngol Otol 119:169-74. 2005..The aim of this review is to examine the current literature in an attempt to develop an approach to the treatment of the elderly patient with head and neck cancer and to define the pertinent issues that require further study...
Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrenceAlexander Stojadinovic
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 9:789-98. 2002..We identified factors predictive of outcome for recurrent differentiated thyroid carcinoma (DTC)...
Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarraysAxel Hoos
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Am J Pathol 160:175-83. 2002..Molecular alterations in the p53 pathway play a role in Hürthle cell tumorigenesis, but other unidentified molecular changes seem to be required to induce the malignant phenotype...
Management of well-differentiated thyroid carcinoma presenting within a thyroglossal duct cystSnehal G Patel
Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
J Surg Oncol 79:134-9; discussion 140-1. 2002..Results of adequate excision using the Sistrunk operation are excellent and the concept of risk-groups should be used to identify patients, who would benefit from more aggressive treatment...
Genome-wide appraisal of thyroid cancer progressionVolkert B Wreesmann
Laboratory of Epithelial Cancer Biology, Head and Neck Service, New York, New York 10021, USA
Am J Pathol 161:1549-56. 2002..Our data suggests that the development of chromosomal instability underlies the progression to more aggressive phenotypes of thyroid cancer and sheds light on the possible genomic aberrations that may be selected for during this process...
Opening the "gift box": a systematic approach to expose the thyroid and superior thyroid vessels in complicated thyroid surgeryDimitrios Moraitis
Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
J Surg Oncol 93:417-9. 2006
Routine laryngoscopy in thyroid surgery: A valuable adjunctAshok R Shaha
Cornell University Medical Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Surgery 142:865-6. 2007
Sentinel lymph node biopsy for cutaneous head and neck melanomasSnehal G Patel
Head and Neck Service, PO Box 285, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Arch Otolaryngol Head Neck Surg 128:285-91. 2002..Although SLNB is a reliable indicator of the status of the draining lymphatic basins in CMHN, patients with negative SLNs must be observed for longer periods to understand the true implications of the procedure...
Incidence of inadvertent parathyroid removal during thyroidectomyDerrick T Lin
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Laryngoscope 112:608-11. 2002..Inadvertent parathyroidectomy did not result in symptomatic temporary or permanent hypocalcemia postoperatively...
The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongueCherry L Estilo
Dental Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 9:2300-6. 2003..3 amplification. This study aimed to delineate the role of SCCRO and PIK3CA in the pathogenesis of oral tongue SCC...
Pathology quiz case 2. Cutaneous angiosarcomaKepal N Patel
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Arch Otolaryngol Head Neck Surg 130:1439, 1440-1. 2004
Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidismBenjamin L Judson
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
J Nucl Med 49:1813-8. 2008..Nuclear imaging is also critical to the successful management of patients with persistent or recurrent hyperparathyroidism...
Training in head and neck surgery and oncologyAshok R Shaha
Cornell University Medical College, New York, New York 10065, USA
J Surg Oncol 97:717-20. 2008..The head and neck surgeon (leader of the orchestra) must be familiar with appropriate indications of each treatment modality and outcome. The head and neck surgeon of today should be an all-rounder...
Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynxJeannette Marie S Matsuo
Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Ann Surg 238:412-21; discussion 421-2. 2003..CONCLUSION: Regardless of the index treatment modality, primary tumor site, or T stage, a higher clinical N stage at the time of presentation independently and significantly increases the risk of DM in patients with SCCL...
Complications of neck dissectionEric M Genden
Department of Otolaryngology--Head and Neck Surgery, Mount Sinai School of Medicine, New York, New York, USA
Acta Otolaryngol 123:795-801. 2003
Current philosophy on the management of cancer of the base of the tongueLouis B Harrison
Department of Radiation Oncology, Beth Israel Medical Center and St Luke's-Roosevelt Hospital Center, New York, NY, USA
Oral Oncol 39:101-5. 2003..This review provides an overview of the treatment options that exist, their advantages and disadvantages, and hopefully provides proper guidelines for the current management of this challenging disease...
Surgical management of recurrent tumor in the neckAlfio Ferlito
Department of Otolaryngology-Head and Neck Surgery, University of Udine, Policlinico Universitario, Italy
Acta Otolaryngol 122:121-6. 2002
Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck?Mohamed N Elsheikh
Department of Otolaryngology-Head and Neck Surgery, Tanta University, Tanta, Egypt
J Am Coll Surg 202:320-3. 2006
Management of N3 neckAlfio Ferlito
Department of Otolaryngology-Head and Neck Surgery, University of Udine, Policlinico Universitario, Italy
Acta Otolaryngol 122:230-3. 2002
Is elective neck treatment indicated in patients with squamous cell carcinoma of the maxillary sinus?Alessandra Rinaldo
Department of Otolaryngology-Head and Neck Surgery, University of Udine, Policlinico Universitario, Italy
Acta Otolaryngol 122:443-7. 2002
Contemporary important considerations in diagnosis and treatment of head and neck cancerAlfio Ferlito
Department of Otolaryngology-Head and Neck Surgery, University of Udine, Policlinico Universitario, Italy
Acta Otolaryngol 122:115-20. 2002
Prospective functional voice assessment in patients undergoing thyroid surgeryAlexander Stojadinovic
Department of Surgery, Walter Reed Army Medical Center, Washington, D.C, USA
Ann Surg 236:823-32. 2002..Factors other than laryngeal nerve injury appear to alter post-thyroidectomy voice. The variability of patient symptoms underscores the importance of understanding the physiology of dysphonia...
"Skip metastases" from head and neck cancersAlfio Ferlito
Acta Otolaryngol 122:788-91. 2002
New molecular diagnostic methods in head and neck cancerJuan Pablo Rodrigo
Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain
Head Neck 27:995-1003. 2005..However, despite the great promise of these new molecular approaches for cancer detection, much of the current technology limits their implementation into routine clinical use...
Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer?Robert Udelsman
Yale University School of Medicine, PO Box 208062, New Haven, CT 06520-8062, USA
Lancet Oncol 6:529-31. 2005
Management of the N0 neck--reference or preferenceWilliam I Wei
Division of Head and Neck Surgery, Otorhinolaryngology, Plastic and Reconstructive Surgery, Department of Surgery, University of Hong Kong Medical Center, Queen Mary Hospital, Hong Kong, Peoples Republic of China
Oral Oncol 42:115-22. 2006....
Neck dissection: then and nowAlfio Ferlito
Department of Surgical Sciences, ENT Clinic, University of Udine, Udine, Italy
Auris Nasus Larynx 33:365-74. 2006..The authors conclude that neck dissection, as evolved over the past century, is a fundamental tool in management of patients with head and neck cancer, but is still a work in progress...
Options for salvage after failed initial treatment of anterior vocal commissure squamous carcinomaPatrick J Bradley
Department of Otorhinolaryngology-Head and Neck Surgery, Queens Medical Centre, Nottingham, UK
Eur Arch Otorhinolaryngol 263:889-94. 2006..However, total laryngectomy may remain the only treatment option for advanced or aggressive first time recurrence, or in patients who develop subsequent recurrence following previous less aggressive surgery (endoscopic or external)...
Elective and therapeutic selective neck dissectionAlfio Ferlito
Department of Surgical Sciences, ENT Clinic, University of Udine, Policlinico Universitario, Piazzale S Maria della Misericordia, 33100 Udine, Italy
Oral Oncol 42:14-25. 2006....
Papillary microcarcinoma of the thyroidAshok R Shaha
J Surg Oncol 95:532-3. 2007
Routine drainage after thyroid surgery--a meta-analysisAlvaro Sanabria
Department of Surgery, Universidad de La Sabana, Bogota, Colombia
J Surg Oncol 96:273-80. 2007..In addition, the mean length of hospital stay was longer in the routine drainage group...
Complications of neck dissection for thyroid cancerAshok R Shaha
Ann Surg Oncol 15:397-9. 2008
Current management of mucosal melanoma of the head and neckJesus E Medina
Department of Otolaryngology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
J Surg Oncol 83:116-22. 2003..A better grasp of the best means of treating MuM will likely come only when large referral centers are able to pool their experiences with these uncommon yet virulent malignancies...
